To review the published clinical data assessing the role of adjunctive rifampin therapy for the treatment of staphylococcal central nervous system (CNS) infections.
DATA SOURCES:
A MEDLINE search (January 1966–March 2000) of English-language literature pertaining to CNS staphylococcal infections and rifampin was performed; tertiary sources were also used.
DATA EXTRACTION:
Human data and case reports were included, as no clinical trials have been published.
DATA SYNTHESIS:
Retrospective reviews of rifampin used in combination with other antibiotics for serious bacterial infections show conflicting results. Few case reports have described clinical successes with adjunctive rifampin therapy for CNS infections.
CONCLUSIONS:
The routine use of adjunctive rifampin for CNS infections cannot be justified.
CDC NNIS System. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1998, issued June 1998. Am J Infect Control1998;26:522–33.
2.
MorrisALowDE. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infect Dis Clin North Am1999;13:735–50.
3.
VichyanoudROlsonLC. Staphylococcal CNS infections treated with vancomycin and rifampin. Arch Neurol1984;41:637–9.
4.
KarchmerAWArcherGLDismukesWE. Staphylococcus epidermidis causing prosthetic valve endocarditis: Microbiologic and clinical observations as guides to therapy. Ann Intern Med1983;98:447–55.
5.
ArcherGLClimoMW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother1994;38:2231–7.
6.
EinMESmithNJArrufoJFHeermaMSBradshawMWWilliamsTW. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother1979;16:655–9.
7.
EngRHKSmithSMTillemMCherubinC. Rifampin resistance: Development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med1985;145:146–8.
8.
AcarJFGoldsteinFWDuvalJ. Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. Rev Infect Dis1983;5(suppl 3):S502–6.
9.
ZinnerSHLagastHKlasterskyJ. Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis1981;144:365–71.
10.
BaystonRHartCABarnicoatM. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry1987;50:1419–23.
McLaurinRLFramePT. Treatment of infections of cerebrospinal fluid shunts. Rev Infect Dis1987;9:595–603.
13.
OsbornJSSharpSHansonEJMacGeeEBrewerJH. Staphylococcus epidermidis ventriculitis treated with vancomycin and rifampin. Neurosurgery1986;19:824–7.
14.
ArcherGLTenenbaumMJHaywoodHB. Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices. JAMA1978;240:751–3.
15.
RobinsonEN. Staphylococcal meningitis can present as an abscess of a single lateral ventricle. Clin Infect Dis1993;16:435–8.
16.
GordonJJHarterDHPhairJP. Meningitis due to Staphylococcus aureus. Am J Med1985;78:965–70.
17.
GombertMELandesmanSHCorradoMLSteinSCMelvinETCummingsM. Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts. J Neurosurg1981;55:633–6.
